Press release MHRA approves GLP –1 receptor agonist semaglutide to lessen chance of significant coronary heart troubles in obese or overweight Grown ups Semaglutide is the very first fat reduction drug authorised in britain being a preventative remedy for the people with recognized heart problemsinflammation of the pancreas (pancreatitis). End us